[{"AccountsPayableCurrent_0_Q3_USD":5332000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":6000000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":13200000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":26355000.0,"ContractWithCustomerAssetNet_0_Q3_USD":6111000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":595000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":1849000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-555000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2985000.0,"OtherLiabilitiesCurrent_0_Q3_USD":710000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":11704000.0,"IncreaseDecreaseInContractWithCustomerAsset_3_Q3_USD":1784000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":31037000.0,"CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-2464000.0,"CapitalLeaseObligationsIncurred_3_Q3_USD":0.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":916000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-5698000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-2104000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_3_Q3_USD":-0.17,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q3_USD":-0.06,"IncomeLossFromDiscontinuedOperationsNetOfTax_3_Q3_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_1_Q3_USD":0.0,"FinanceLeasePrincipalPayments_3_Q3_USD":78000.0,"DeferredRentCreditNoncurrent_0_Q3_USD":0.0,"DepreciationDepletionAndAmortization_1_Q3_USD":800000.0,"DividendsPreferredStock_3_Q3_USD":3244000.0,"DividendsPreferredStock_1_Q3_USD":1081000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-9302000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-3546000.0,"PaymentsOfDividendsPreferredStockAndPreferenceStock_3_Q3_USD":3244000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":2276000.0,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3_Q3_USD":0.0,"GainLossOnDispositionOfIntangibleAssets_3_Q3_USD":0.0,"GainLossOnTerminationOfLease_1_Q3_USD":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":187000.0,"ShortTermLeaseCost_1_Q3_USD":83000.0,"ShortTermLeaseCost_3_Q3_USD":83000.0,"RestrictedCash_0_Q3_USD":350000.0,"ProceedsFromStockPlans_3_Q3_USD":187000.0,"ProceedsFromSaleOfIntangibleAssets_3_Q3_USD":0.0,"PreferredStockDividendsPerShareCashPaid_1_Q3_USD":0.6563,"PreferredStockDividendsPerShareCashPaid_3_Q3_USD":1.9688,"PreferredStockDividendsIncomeStatementImpact_1_Q3_USD":1442000.0,"PreferredStockDividendsIncomeStatementImpact_3_Q3_USD":3604000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.08,"OperatingLeaseRightOfUseAsset_0_Q3_USD":20437000.0,"OperatingLeasePayments_3_Q3_USD":2300000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":21584000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1172000.0,"OperatingLeaseLiability_0_Q3_USD":22756000.0,"OperatingLeaseCost_1_Q3_USD":798000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_3_Q3_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_1_Q3_USD":0.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-32000.0,"InterestCostsIncurred_3_Q3_USD":0.0,"LeaseCost_3_Q3_USD":3141000.0,"LeaseCost_1_Q3_USD":1036000.0,"GainLossOnTerminationOfLease_3_Q3_USD":-355000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":34736000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":3086000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":3010000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2995000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2972000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":11980000.0,"OperatingLeaseCost_3_Q3_USD":2570000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":21938000.0,"OtherAssetsNoncurrent_0_Q3_USD":302000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-2104000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-5698000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":2780000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-3025000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-2219000.0,"LiabilitiesCurrent_0_Q3_USD":36554000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":105216000.0,"Liabilities_0_Q3_USD":58138000.0,"InventoryNet_0_Q3_USD":9565000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":54000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2777000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":491000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-2104000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-5698000.0,"GrossProfit_1_Q3_USD":785000.0,"GrossProfit_3_Q3_USD":5231000.0,"GainLossOnDispositionOfAssets_3_Q3_USD":-13000.0,"AccountsReceivableNetCurrent_0_Q3_USD":10151000.0,"AdditionalPaidInCapital_0_Q3_USD":613323000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":347000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":232000.0,"Assets_0_Q3_USD":105216000.0,"AssetsCurrent_0_Q3_USD":57277000.0,"NetIncomeLoss_3_Q3_USD":-5698000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":30687000.0,"CommonStockSharesOutstanding_0_Q3_shares":56479000.0,"CommonStockValue_0_Q3_USD":56000.0,"CostOfRevenue_3_Q3_USD":41921000.0,"CostOfRevenue_1_Q3_USD":12800000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.17,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.06,"CommonStockSharesIssued_0_Q3_shares":56479000.0,"NetIncomeLoss_1_Q3_USD":-2104000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3025000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":763000.0,"PreferredStockValue_0_Q3_USD":2000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":10989000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":2996000.0,"ShareBasedCompensation_3_Q3_USD":1849000.0,"ShareBasedCompensation_1_Q3_USD":595000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":916000.0,"PreferredStockSharesOutstanding_0_Q3_shares":1648000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":484000.0,"IncreaseDecreaseInInventories_3_Q3_USD":3008000.0,"InterestAndOtherIncome_3_Q3_USD":415000.0,"InterestAndOtherIncome_1_Q3_USD":107000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":735000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":43677000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":489000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":16827000.0,"VariableLeaseCost_3_Q3_USD":488000.0,"PreferredStockSharesIssued_0_Q3_shares":1648000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PropertyPlantAndEquipmentNet_0_Q3_USD":26850000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-566303000.0,"Revenues_3_Q3_USD":47152000.0,"Revenues_1_Q3_USD":13585000.0,"StockholdersEquity_0_Q3_USD":47078000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":56275000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":56404000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"OperatingExpenses_3_Q3_USD":11344000.0,"OperatingExpenses_1_Q3_USD":2996000.0,"OperatingIncomeLoss_3_Q3_USD":-6113000.0,"OperatingIncomeLoss_1_Q3_USD":-2211000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"VariableLeaseCost_1_Q3_USD":155000.0,"Ticker":"CDMO","CIK":"704562","name":"AVID BIOSERVICES, INC.","OfficialName":"Avid Bioservices Inc. Common Stock","form":"10-Q","period":"20200131","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1130539049.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200310"}]